NDATOPICALSPRAY
Approved
Oct 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15
Data completeness
3/8 — Basic
KENALOG (triamcinolone acetonide) by PharmaIN is corticosteroid hormone receptor agonists [moa]. First approved in 1974.
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KENALOG (triamcinolone acetonide) is a topical corticosteroid spray that works by agonizing corticosteroid hormone receptors to reduce inflammation. It treats diabetic macular edema, acute gout, atopic dermatitis, uveitis, and acute gouty arthritis. The drug has been on the market since 1974 and remains a foundational anti-inflammatory therapy across multiple therapeutic areas.
LOE Approaching
As LOE approaches, the brand team is likely contracting; opportunities exist in generic transition planning and cost-management strategies rather than growth initiatives.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (15)
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Started Oct 2020
40 enrolled
Drug-Drug Interaction
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
Started Mar 2018
325 enrolled
Macular EdemaRetinal Vein Occlusion
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Started Jan 2017
460 enrolled
Macular EdemaRetinal Vein Occlusion
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
Started Nov 2015
0UveitisCystoid Macular Edema
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Started Jan 2015
46 enrolled
Macular EdemaRetinal Vein Occlusion
Worked on KENALOG at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.